Healthcare & Life Sciences
Lycia Therapeutics
United Stateslyciatherapeutics.com
Lycia Therapeutics is a series c plus startup. 1 investor tracked. Status: possibledead.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Lycia Therapeutics
Lycia Therapeutics is a startup founded in 2018 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Lycia Therapeutics develops molecular glue therapeutics that induce protein degradation to treat diseases currently considered undruggable.
Explore Lycia Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.